Evidence map›Paper›PMID 41848597›Full record

Trial reportBJU international2026

Patient-reported outcome measures of percutaneous nephrostomy vs JJ stent in obstructive urolithiasis: results of the STent Or NEphrostomy (STONE) randomised controlled trial.

Hugo W Schuil, Nora Hendriks, Ruben G Duijnhoven, Bart C H Oskam, Tom J H Arends, Diederick Duijvesz, Alexander D Horsch, Bart van der Heij, Irene M Tjiam, Hans van Overhagen and 16 more

Abstract readRandomized Controlled TrialMulticenter StudyComparative Study
In one paragraph

Trial report in BJU international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Hugo W SchuilDepartment of Urology, Alrijne Ziekenhuis, Leiderdorp, The Netherlands.ORCID 0000-0003-3494-9268
Nora HendriksDepartment of Urology, Alrijne Ziekenhuis, Leiderdorp, The Netherlands.ORCID 0000-0002-4605-6283
Ruben G DuijnhovenClinical Trials Unit, Healthcare Evaluation and Research, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Bart C H OskamDepartment of Urology, Meander Medisch Centrum, Amersfoort, The Netherlands.
Tom J H ArendsDepartment of Urology, Meander Medisch Centrum, Amersfoort, The Netherlands.
Diederick DuijveszDepartment of Urology, Canisius Wilhelmina Ziekenhuis, Nijmegen, The Netherlands.
Alexander D HorschDepartment of Radiology, Alrijne Ziekenhuis, Leiderdorp, The Netherlands.
Bart van der HeijDepartment of Urology, Zuyderland Medisch Centrum, Heerlen, The Netherlands.
Irene M TjiamDepartment of Urology, Haga Ziekenhuis, The Hague, The Netherlands.
Hans van OverhagenDepartment of Radiology, Haga Ziekenhuis, The Hague, The Netherlands.
Armand B G N LamersDepartment of Radiology, Amsterdam UMC, Amsterdam, The Netherlands.
Otto M van DeldenDepartment of Radiology, Amsterdam UMC, Amsterdam, The Netherlands.
Wout A ScheepensDepartment of Urology, Catharina Ziekenhuis, Eindhoven, The Netherlands.
Jamie M A DrossaertsDepartment of Urology, Catharina Ziekenhuis, Eindhoven, The Netherlands.
Frank C H d'AnconaDepartment of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Steven BoeringDepartment of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Janneke I M van UhmDepartment of Urology, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0002-0589-3229
Rutger W van der MeerDepartment of Radiology, Leiden University Medical Center, Leiden, The Netherlands.
J Herman van RoijenDepartment of Urology, Elisabeth-TweeSteden Ziekenhuis, Tilburg, The Netherlands.
Martin de KiefteDepartment of Radiology, Elisabeth-TweeSteden Ziekenhuis, Tilburg, The Netherlands.
Ad J M HendrikxDepartment of Urology, Catharina Ziekenhuis, Eindhoven, The Netherlands.
Saskia WeltingsDepartment of Urology, Zaans Medisch Centrum, Zaandam, The Netherlands.ORCID 0000-0002-6587-2251
Rob C M PelgerDepartment of Urology, Leiden University Medical Center, Leiden, The Netherlands.
Harrie P BeerlageDepartment of Urology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Barbara M A SchoutDepartment of Urology, Alrijne Ziekenhuis, Leiderdorp, The Netherlands.
Guido M KamphuisDepartment of Urology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Funding

leading the change
6 · The paper itself

Abstract

objectiveTo compare the effects of percutaneous nephrostomy (PCN) and JJ ureteric stent (JJ) for urinary tract decompression in patients with obstructive urolithiasis on health-related quality of life (HRQoL), pain scores, urinary symptoms, and patient satisfaction. PATIENTS AND

methodsIn 11 hospitals, 204 patients with obstructive urolithiasis were randomised to JJ or PCN placement. Patient-reported outcome measures (PROMs) were assessed until stone passage, surgical removal, or at 3 months.

resultsBoth PCN and JJ effectively improved HRQoL index scores (PCN: pre-decompression 0.70, 1 day post-decompression 0.82, P = 0.003; JJ: pre 0.59, post 0.85, P < 0.001), pain scores (PCN: pre 4.9, post 1.3, P < 0.001; JJ: pre 5.5, post 1.3, P < 0.001), and achieved patient satisfaction (score at discharge PCN: 7.9; JJ: 8.2), with no significant differences between interventions in overall HRQoL (generalised estimating equation [GEE] P = 0.7) or mean daily pain scores (GEE P = 0.4). PCN led to more self-care difficulties (patients reporting no problems: PCN 74%, JJ 91%, P = 0.023), while JJ recipients reported more urinary symptoms and higher peak pain intensity (pain score PCN: 2.3, JJ: 3.7, between groups P = 0.018). Despite symptoms, more JJ recipients preferred the same intervention in future (60%), than PCN recipients (31%) (P < 0.001). Survey-based data collection may introduce response bias (response rate 59%).

conclusionIn patients with obstructive urolithiasis, urinary decompression with PCN and JJ improved HRQoL and pain comparably. JJ causes more urinary symptoms and peak pain but allows better self-care. Baseline self-care and urinary symptoms should guide shared decision-making. Drainage duration should be minimised.

Indexed as

Nephrostomy, PercutaneousPatient Reported Outcome MeasuresStentsUreteral ObstructionUrolithiasisAdultAgedFemaleHumansMaleMiddle AgedPatient SatisfactionQuality of LifeTreatment Outcomehealth‐related quality of lifeJJ ureteric stentobstructive urolithiasispercutaneous nephrostomyPROMsrandomised controlled trial

Identifiers

PMID41848597
PMCPMC13168918

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.